v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss) income $ (1,757,914) $ 2,991,203
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 2,518 390,499
Stock compensation expense 783,762 1,114,467
Amortization of deferred origination fees (55,842)
Operating lease (2,172) 18,594
Provision (benefit) for credit losses (166,035)
Income tax (benefit)/expense 45,953
Change in the fair value of deferred consideration (120,040) (396,070)
Change in fair value of warrant (1,254,240) (2,341,773)
Changes in operating assets and liabilities:    
Accounts receivable – trade 83,674 1,092,069
Accounts receivable – related party 385,168 (180,874)
Prepaid expenses 317,545 243,335
Accrued interest receivable 14,214 (9,469)
Other assets (286,672) 82,206
Other current liabilities (58,370) 25,203
Accounts payable 486,818 (62,950)
Accounts payable – related party 89,309 (474,057)
Accrued expenses (480,811) (59,296)
Contract liabilities (18,127) 44,873
Net deferred indemnified loan origination fees 402,601
Net cash provided by (used in) operating activities (1,815,338) 2,704,637
CASH FLOWS PROVIDED BY INVESTING ACTIVITIES:    
Proceeds from loan repayment 6,545 6,083
Net cash provided by investing activities 6,545 6,083
CASH FLOWS USED IN FINANCING ACTIVITIES:    
Net share settlement for stock compensation expense (12,771)
Repayment of senior secured promissory note (255,765) (1,487,507)
Net cash used in financing activities (268,536) (1,487,507)
Net (decrease) increase in cash and cash equivalents (2,077,329) 1,223,213
Cash and cash equivalents – beginning of period 2,324,647 4,888,769
Cash and cash equivalents – end of period 247,318 6,111,982
Supplemental disclosure of cash flow information    
Interest paid 228,901 325,327
Supplemental disclosure of non-cash investing and financial activities    
Reclassification of forward purchase receivable $ (4,584,221)